CSI Market
Sign In | Register

Zyversa Therapeutics Inc (ZVSA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ZVSA Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Zyversa Therapeutics Inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent0.30
Deposits Assets, Current AS0.00
Cash & Short-term Investments0.00
Prepaid Expense And Other Assets Current0.44
Total Current Assets0.74
Deposits Assets, Noncurrent AS0.00
Deferred Tax Assets, in Process Research and Development0.00
Deferred Costs, Noncurrent AS0.00
Other Assets, Noncurrent0.00
Total Assets0.74
Liabilities
Accounts Payable, Current AC10.24
Accrued Liabilities, Current AC3.30
Convertible Notes Payable, Current NO1.20
Other Liabilities, Current0.00
Total Current Liabilities14.87
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
DeferredIncomeTaxLiabilitiesNet-
Warrant Liability0.13
Total Liabilities14.87
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value-0.01
Additional Paid In Capital Common Stock125.26
Retained Earnings / Accumulated Deficit-139.38
Other Equity0.00
Common Stockholder's Equity-14.12
Total Stockholder's Equity-14.12
Liabilities & Stockholder's Equity0.74
4 historic quarters locked

Sign in to unlock the full Zyversa Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Zyversa Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260331)
  • Filed with the SEC: May 13, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-022759

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.